Jeong Won Park Selected Research

Thyroid Hormone Receptors (Thyroid Hormone Receptor)

1/2020	Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
1/2017	Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
1/2017	Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
10/2014	Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity.
9/2014	Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice.
9/2014	Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
5/2014	A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
1/2013	Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong Won Park Research Topics

Disease

11	Neoplasms (Cancer) 08/2021 - 03/2012
6	Breast Neoplasms (Breast Cancer) 08/2021 - 09/2007
4	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 03/2012
3	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2012
2	Hypothyroidism 05/2014 - 05/2013
1	Cholangiocarcinoma 05/2020
1	Circulating Neoplastic Cells 05/2020
1	Otitis Media 10/2019
1	Sensorineural Hearing Loss 10/2019
1	Conductive Hearing Loss 10/2019
1	Cholesteatoma 10/2019
1	Otitis Media with Effusion 10/2019
1	Hyperplasia 01/2017
1	Obesity 01/2017
1	Anaplasia 01/2016
1	follicular Thyroid cancer 09/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2014
1	Carcinogenesis 01/2013
1	Hypercalcemia (Milk Alkali Syndrome) 01/2009
1	Pathologic Neovascularization 05/2008
1	Alzheimer Disease (Alzheimer's Disease) 05/2008

Drug/Important Bio-Agent (IBA)

8	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2020 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2008
3	Retinoblastoma ProteinIBA 01/2017 - 08/2013
3	Co-Repressor ProteinsIBA 05/2014 - 01/2013
2	VimentinIBA 05/2020 - 01/2016
2	Thyroid HormonesIBA 01/2020 - 05/2013
2	Cyclin D1IBA 01/2017 - 08/2013
2	NSC 74859IBA 01/2017 - 01/2016
1	AntioxidantsIBA 08/2021
1	sodium propionateIBA 08/2021
1	p38 Mitogen-Activated Protein KinasesIBA 08/2021
1	Drinking WaterIBA 08/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2021
1	Epithelial Cell Adhesion MoleculeIBA 05/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	AntibodiesIBA 05/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020
1	ChromatinIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	C-Type Lectins (C-Type Lectin)IBA 10/2019
1	LeptinIBA 01/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Cyclin-Dependent Kinase 4IBA 01/2016
1	CyclinsIBA 01/2016
1	Histone Deacetylase InhibitorsIBA 05/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2013
1	Cyclin DIBA 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	bosutinibIBA 03/2012
1	IonsIBA 01/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2008
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2007

Therapy/Procedure

2	Therapeutics 05/2014 - 05/2013
1	Lab-On-A-Chip Devices 05/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 08/2013